Handelsbanken Fonder AB Has $322,000 Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)

Handelsbanken Fonder AB lifted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 7.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,900 shares of the medical research company’s stock after acquiring an additional 1,300 shares during the period. Handelsbanken Fonder AB’s holdings in NeoGenomics were worth $322,000 as of […]

Related Keywords

United Kingdom ,United States ,Alger ,Algeria ,Piper Sandler ,Aliciac Olivo ,Jennison Associates ,Securities Exchange Commission ,Neogenomics Company Profile ,Nasdaq ,Clinical Services ,Goldman Sachs Group ,Holdings Channel ,Neogenomics Inc ,Schroder Investment Management Group ,Fred Alger Management ,Needham Company ,Emerald Advisers ,Brown Advisory Inc ,Handelsbanken Fonder ,Free Report ,Investment Management Group ,Alger Management ,General Counsel Alicia ,Exchange Commission ,Get Free Report ,Advanced Diagnostics ,Visit Holdingschannel ,Neogenomics Daily ,Neogenomics ,Nasdaq Neo ,Neo ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,